supercat
Major
An inactivated COVID-19 vaccine from China National Biotec Group (CNBG), which is affiliated with Sinopharm, has started phase 3 trial in Argentina, as well as in the United Arab Emirates, Peru, and Morocco.
Indonesia inks deal with China on virus vaccine supply from November
Indonesia and China agreed Thursday that a Chinese pharmaceutical company working with a state-owned Indonesian drugmaker will send up to 40 million doses of a coronavirus vaccine to the Southeast Asian county starting in November.
The agreement was announced by Foreign Minister Retno Marsudi in a virtual press conference after a meeting with her Chinese counterpart Wang Yi.
"A commitment was agreed on the supply of vaccine bulk up to 40 million doses from November 2020 to March 2021," Retno told reporters, saying the agreement was signed between Chinese drugmaker Sinovac Biotech Ltd. and Indonesia's PT Bio Farma.
Since last week, Indonesia has been conducting the final, phase 3 clinical testing for the COVID-19 vaccine candidate in the West Java provincial capital of Bandung.
The trial is taking place with the cooperation of Sinovac, which developed the vaccine candidate, with support from Bio Pharma and a team of Indonesian scientists and researchers.